CHEPLAPHARM Arzneimittel GmbH
support_agent

Your contact persons

INHIBACE® / INHIBACE® PLUS

Active ingredient:

Cilazapril Cilazapril / Hydrochlorothiazide

Therapeutic area:

Cardiology

INHIBACE® is a classical angiotensin-converting enzyme (ACE) inhibitor with active substance cilazapril. It is indicated in the treatment of hypertension and chronic heart failure.

INHIBACE® PLUS further contains the combination with hydrochlorothiazide and is indicated in the treatment of hypertension in patients not responding satisfactorily to each component administered alone.

ACE inhibitors in combination with other anti-hypertensives like beta-blockers, calcium channel antagonists, angiotensin receptor blockers, diuretics, thiazides etc. are commonly used in clinical practice. According to clinical practice guidelines, ACE inhibitors are generally considered as first line therapy for hypertension.

Back to top expand_less